Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharmaceutical intermediates manufacturing with improved atom economy.
Novel silver oxide promoted method for 5-trifluoromethyl imidazole. Offers scalable, cost-effective pharmaceutical intermediate manufacturing with high yield and purity.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via simplified processing.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective manufacturing and high purity for pharmaceutical applications.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN113429349A details a heterogeneous copper-catalyzed route for 2-trifluoromethyl benzimidazoles, offering scalable pharma intermediate production with recyclable catalysts.
Patent CN113307790B reveals a metal-free oxidative cyclization for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113429349A details a heterogeneous copper-catalyzed route for high-purity benzimidazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and high purity.
Patent CN113105402A reveals a novel iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalability.
Novel Pd-catalyzed multicomponent method for carbonyl-bridged biheterocycles. Efficient, scalable, CO-free process for pharma intermediates.
Novel palladium-catalyzed route for alpha-amino acid esters using alkenyl ethers. Offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing.
Patent CN115353511A discloses a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer conditions and high yields for API manufacturing.
Patent CN113105402A reveals a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN106938976B enables transition-metal-free imine synthesis. Achieve high-purity pharmaceutical intermediates with reduced environmental costs and scalable production.